GlassScriptPhysician profile
Kory P Schrom
NPI 1326492851
$5,941.00
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,325 · 2020: $152 · 2021: $157 · 2022: $3,442 · 2023: $655 · 2024: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $3,045.34 | 2019-2023 | Dupixent |
| Abbvie INC. | $863.64 | 2019-2024 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $445.63 | 2019-2022 | |
| Genzyme Corporation | $335.90 | 2019-2023 | |
| Ucb, INC. | $198.67 | 2019-2022 | |
| Janssen Biotech, INC. | $136.66 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.59 | 2022 | |
| Sun Pharmaceutical Industries INC. | $124.55 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $123.42 | 2022 | |
| Amgen INC. | $115.20 | 2023 | Otezla |
| Kyowa Kirin, INC. | $113.00 | 2019 | |
| Dermavant Sciences, INC. | $71.40 | 2023-2024 | Vtama |
| Lilly USA, LLC | $60.13 | 2019-2023 | Taltz |
| Incyte Corporation | $49.53 | 2023 | Opzelura |
| Celgene Corporation | $48.51 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $21.00 | 2019 | |
| Galderma Laboratories, L.P. | $18.82 | 2023 | Aklief, Oracea |
| Tactile Systems Technology INC | $18.77 | 2022 | |
| Epi Health, LLC | $17.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kory Schrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.